Related Experiment Video
Updated: May 4, 2026
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
Scn4b Modulates Huntington's Disease Phenotype Severity in vivo
Insights
Huntington's disease (HD) involves the HTT gene, but neuron loss remains unclear. This study reveals SCN4B gene loss contributes to HD, while its overexpression rescues HD symptoms and improves neuron function, suggesting SCN4B as a therapeutic target.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is caused by CAG trinucleotide repeat expansions in the HTT gene.
- The precise mechanisms leading to neuronal cell loss in HD, particularly striatal spiny projection neurons (SPNs), are not fully understood.
Purpose of the Study:
- To investigate the role of the SCN4B gene in Huntington's disease pathogenesis.
- To explore SCN4B as a potential therapeutic target for HD.
Main Methods:
- Utilized mouse models (wild-type and HD) to study SCN4B function in vivo.
- Employed single nucleus RNA sequencing (snRNA-seq) to analyze gene expression changes in the striatum.
- Assessed motor and cognitive deficits, and SPN electrophysiological properties.
Main Results:
- Loss of SCN4B in wild-type mice mimicked HD-associated phenotypes.
- Overexpression of SCN4B in an HD mouse model rescued motor and cognitive deficits.
- Loss of SCN4B replicated HD-associated gene expression signatures, while SCN4B overexpression rescued these signatures and improved SPN electrophysiology.
Conclusions:
- Reduced SCN4B expression is implicated as a significant contributor to HD pathogenesis.
- SCN4B modulation presents a potential therapeutic strategy for Huntington's disease.
Abstract:
Although it has been known for over 30 years that CAG trinucleotide repeat expansions in the HTT gene are the cause of Huntington's disease (HD), it is still not understood how these mutations lead to the loss of striatal spiny projection neurons (SPNs) and other vulnerable neuronal cell types in HD. Here we show that SCN4B , a gene that is enriched in neurons that influence motor function, including striatal SPNs, modulates HD-associated phenotypes in vivo . Loss of Scn4b in wild-type mice mimics and Scn4b overexpression in an HD mouse model rescues several HD-associated phenotypes, including motor and cognitive deficits. Single nucleus RNA sequencing (snRNA-seq) analysis reveals that loss of Scn4b replicates several HD-associated gene expression signatures in the striatum. Conversely, overexpression of Scn4b rescues HD gene expression signatures and improves various SPN electrophysiological properties in HD model mice. Taken together, our results implicate loss of Scn4b expression as an important contributor to HD pathogenesis and therapeutic target in HD.
